Key opinion leaders analyze the efficacy, safety profile, and proper utilization of behind-the-counter medications such as pseudoephedrine products, exploring their mechanisms of action and potential adverse effects, while also providing strategies for pharmacists to identify contraindications, drug interactions, and appropriate dosing regimens for…

Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.Από τον MJH Life Sciences

A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.Από τον MJH Life Sciences

Plaque psoriasis experts explore recent advancements in treatment options, patient experiences, and the potential of novel oral systemic therapies to reduce the burden of this prevalent chronic condition.Από τον MJH Life Sciences

Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.Από τον MJH Life Sciences

Dermatologic experts explore strategies to slow the progression of psoriasis to psoriatic arthritis, offering evidence-based insights to optimize patient outcomes and enhance long-term disease management.Από τον MJH Life Sciences

Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.Από τον MJH Life Sciences

A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.Από τον MJH Life Sciences

A panel of dermatologists have a comprehensive discussion on exciting developments in the treatment of plaque psoriasis, focusing on treatment approaches, patient monitoring strategies, and recent clinical trial data.Από τον MJH Life Sciences

Experts give important background information on respiratory syncytial virus (RSV), as well as the key clinical considerations that are associated with RSV vaccine use.Από τον MJH Life Sciences

A panel of ophthalmologists discuss how retinal disease management has evolved in the past decade and continues to change with advancements in diagnostics and therapies.Από τον MJH Life Sciences

Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.Από τον MJH Life Sciences

Medical experts discuss developments in the treatment landscape of moderate plaque psoriasis, including a novel oral systemic treatment which provides an opportunity to alleviate disease burden.Από τον MJH Life Sciences

Experts discuss treating dry eye with procedural therapies, focusing on common in-office and at-home treatments.Από τον MJH Life Sciences

Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.Από τον MJH Life Sciences

Experts discuss the management of dry eye in the presence of concurrent ocular conditions, as well as managing dry eye before undergoing cataract and refractive surgery.Από τον MJH Life Sciences

Experts discuss the management of dry eye using conventional and new pharmacological treatments, as well as strategies for tailoring treatment approaches to individual patient characteristics.Από τον MJH Life Sciences

Expert neurologists discuss strategies to widen the therapeutic window of Parkinson’s disease and options available to treat dyskinesia, providing better control of Parkinson’s disease.Από τον MJH Life Sciences

Advanced practice providers in dermatology discuss exciting developments in the treatment landscape of plaque psoriasis. Listen to their insights into the often-challenging journey patients go on. The arrival of novel oral systemic treatment options offers opportunities to alleviate the burden of this chronic disease.…

The expert neurologists discuss non-motor symptoms of Parkinson’s disease: types, their impact on patient’s quality of life, and current and emerging treatment options for non-motor symptoms.Από τον MJH Life Sciences

In this discussion, experts focus on emerging treatment options for gout and share tips for monitoring and managing gout in patients with comorbid conditions.Από τον MJH Life Sciences

The neurology doctors discuss motor fluctuations and dyskinesia associated with Parkinson’s Disease.Από τον MJH Life Sciences

Expert rheumatologists discuss current treatment options for lupus nephritis and emerging therapies with newer mechanisms of action.Από τον MJH Life Sciences

Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.Από τον MJH Life Sciences

In this episode of MEDcast, expert dermatologists delve into the practical aspects of using photodynamic therapy (PDT) for treatment of actinic keratosis. Specialists are sharing their protocols, advances in PDT delivery, tips for training clinical staff and communicating with patients.Από τον MJH Life Sciences

Expert rheumatologists discuss precision medicine in rheumatoid arthritis. In particular, they discuss available data and the value of various tools in guiding treatment selection in routine clinical practice.Από τον MJH Life Sciences

The neurology experts discuss the importance of early and accurate diagnosis of Parkinson’s disease, the role of alpha-synuclein in the diagnosis of synucleinopathies and approaches to implementing screening protocols in clinical practice.Από τον MJH Life Sciences

Retina specialists evaluate the effectiveness of the two new therapies for neovascular AMD and DME by analyzing their respective clinical trial methodologies and outcomes.Από τον MJH Life Sciences

In this episode of MEDcast, the expert panelists discuss emerging agents for treatment of schizophrenia and what we can be done to improve physician burnout. They also share approaches to creating hope for patients with schizophrenia and to improving treatment compliance.Από τον MJH Life Sciences

Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.Από τον MJH Life Sciences

Experts discuss the intricate relationship between diabetes, kidney disease, and cardiovascular function and explore the evolving landscape of therapies with cardiorenal benefits.Από τον MJH Life Sciences

In this episode of MEDcast, expert dermatologists discuss actinic keratosis, a premalignant skin condition. They are sharing their thoughts on the importance of early diagnosis and treatment and are delving into treatment options, in particular photodynamic treatments.Από τον MJH Life Sciences

Dhiren Patel, PharmD, and Bob Busch, MD, interview Fatima Cody Stanford, MD, MPH, MPA, an obesity medicine specialist, to examine the cardiovascular (CV) impact of obesity and delve into the potential benefits of newer weight loss medications in mitigating CV risk and heart failure.Από τον MJH Life Sciences

In this episode of MEDcast, the expert panelists review newest guidance for prescription of controlled substances using telemedicine, ADHD medication shortage, and approved and emerging stimulants and non-stimulants for the treatment of ADHD.Από τον MJH Life Sciences

In this MEDcast episode, Drs. Soloman, Sharobeem, and Mease discuss newer mechanisms of actions and emerging therapies in rheumatic diseases and tools that are becoming available to rheumatologists to practice precision medicine.Από τον MJH Life Sciences

In this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.Από τον MJH Life Sciences

In this MEDcast episode, Drs Soloman, Sharobeem, Boone and Feldman discuss the use of step therapy in rheumatoid arthritis, how step therapy was intended to be used, how it is actually used, and challenges and solutions to its use.Από τον MJH Life Sciences

In this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.…

In this MEDcast episode, Diana Isaacs, PharmD, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, interview Dr Juan Frias to explore the mechanism of GLP-1 and GIP agonists in diabetes and weight management and examine key findings from clinical trials for the latest GLP-1/GIP dual agonist.Από τον MJH Life Sciences

In this episode of MEDcast, expert geriatric psychiatrist and neurologist delve into the recent advances in the treatment of Alzheimer’s dementia. We will discuss treatments that are on the cusp of FDA approval and others that are coming down the pipeline.Από τον MJH Life Sciences

In this MEDcast episode, Dr Chovatiya and Dr Bunick delve into the advancements in targeted treatments for vitiligo, exploring their potential to provide long-term efficacy and durable clinical response.Από τον MJH Life Sciences

In this episode of MEDcast, Dr Krieger, Dr Brandstadter, and Dr Bove discuss MS care in patients who are considering pregnancy. They highlight treatment options, monitoring recommendations during and after pregnancy, as well as other crucial considerations when caring for patients with childbearing goals.…

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP:-BC, interview Dr Robert Busch, to explore the advantages of SGLT2 inhibitors in chronic kidney disease, cardiovascular health, and their potential to improve overall patient outcomes.Από τον MJH Life Sciences

Expert geriatric psychiatrists explore a frequently encountered symptom in Alzheimer’s disease, agitation. We will discuss its impact on patient’s and care giver’s quality of life, the current standard of care and the first FDA approved agent for treatment of agitation symptoms in Alzheimer’s disease.…

In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis.Από τον MJH Life Sciences

Dr Krieger, Dr Brandstadter, and Dr Lublin discuss the advances made in recognizing and managing multiple sclerosis over the last few decades and the challenges that remain.Από τον MJH Life Sciences

In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.Από τον MJH Life Sciences

In this episode of MEDcast, expert neurologists delve into anti-CD20 disease modifying therapies (DMTs) in MS. They assess the correlation between clinical observations and immunological processes in MS patients, and also examine the role of the Epstein Barr virus in MS.Από τον MJH Life Sciences

In this episode of MEDcast, Dr Julia Blanchette joins Diana Isaacs, PharmD, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, discuss strategies to empower young adults with the skills and resources necessary to effectively manage type 1 diabetes and maintain a healthy lifestyle.Από τον MJH Life Sciences

A therapy has reached the pediatric vitiligo market—and more are on the way. Dermatologists Raj Chovatiya, MD, PhD, and Lawrence Eichenfield, MD, review the major shifts in pediatric vitiligo care and pharmacotherapy developments live from the Revolutionizing Atopic Dermatitis (RAD) 2023 Annual Meeting in Washington, DC.…